Abstract
The subgroup of young patients with non-small-cell lung cancer (NSCLC) is poorly understood. We retrospectively studied the clinical characteristics, gene mutations, and outcomes of patients with NSCLC (aged ≤ 40 years).
Funding Information
  • The National Natural Science Foundation of China (No. 81572273, No. 81602015)
  • Clinical Science and Technology Project of Jiangsu Province (No. BL2013026)

This publication has 23 references indexed in Scilit: